The Prenatal DNA Sequencing by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Prenatal DNA Sequencing Market
https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report
According to The Business Research Company’s Prenatal DNA Sequencing, The prenatal dna sequencing market size has grown rapidly in recent years. It will grow from $2.23 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to changing patient preferences, medical advancements and research, non-invasive testing adoption, rising maternal age, improved accuracy and reliability.
The prenatal dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.56 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to consumer demand for early detection, rising maternal age and pregnancy risks, public health initiatives, regulatory support and guidelines, advancements in data analysis. Major trends in the forecast period include research and development efforts, ethical and regulatory considerations, improved data interpretation tools, precision medicine integration, prenatal genetic counseling.
The increasing prevalence of cancer is expected to propel the growth of the prenatal DNA sequencing market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. Prenatal DNA sequencing in cancer is used to detect fetal aneuploidy in maternal plasma and to identify cancer in the fetus. The sequencing reveals the inherited or germline DNA changes that raise a person’s chance of developing cancer. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. , Therefore, the prevalence of cancer is driving the prenatal DNA sequencing market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9015&type=smp
The Prenatal Dna Sequencing Market Covered In This Report Is Segmented –
1) By Type: Genetic Diseases, Nonhereditary Diseases
2) By Application: Hemophilia, Down Syndrome, Cystic Fibrosis, Autism, DiGeorgre Syndrome, AIDS (Acquired Immunodeficiency Syndrome), Cancer, Other Applications
3) By End User: Academic Research, Clinical Research, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End User
Product innovation is a key trend gaining popularity in the prenatal DNA sequencing market. Major companies operating in the market are focused on developing innovative solutions to strengthen their market position. For instance, in November 2022, Juno Diagnostics, Inc., a US-based health technology company that democratizes access to valuable genetic information, launched the noninvasive prenatal screening test “Hazel”. The test is uniquely designed with no risk of miscarriage, and it can be performed as early as 9 weeks into pregnancy by using a small amount of blood. It screens the pregnancy for common genetic conditions caused by extra or missing chromosomes, such as Down syndrome, Edwards syndrome, and Patau syndrome.
The Prenatal DNA Sequencing Market Report Table Of Contents Includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
……..
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Humira drug, or adalimumab, refers to an injection prescribed to treat rheumatoid…
Overview and Scope Ligase enzymes refer to a class of proteins that catalyze the joining…
Overview and Scope Human Papillomavirus (HPV) Vaccine refers to a vaccine that aids in preventing…
Overview and Scope The human liver model refers to the model of dual-lobed liver of…
Overview and Scope The left ventricular assist device is a mechanical pump implanted in heart…
Overview and Scope Maple syrup is a sweet, dense, and sticky syrup prepared from the…